Point72 Asset Management, L.P. 13D and 13G filings for Atara Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Point72 Asset Management, L.P. | 8,647 0.200% | -176,719 (-95.34%) | Filing |
| 2022-02-14 4:28 pm Purchase | 2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Point72 Asset Management, L.P. | 185,366 5.200% | 2,645 (+1.45%) | Filing |
| 2021-12-21 5:13 pm Purchase | 2021-12-20 | 13G | Atara Biotherapeutics, Inc. ATRA | Point72 Asset Management, L.P. | 182,721 5.200% | 182,721 (New Position) | Filing |